Dihydroresveratrol

TargetMol
Product Code: TAR-T3840
Supplier: TargetMol
CodeSizePrice
TAR-T3840-1mg1mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3840-1mL1 mL * 10 mM (in DMSO)£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3840-5mg5mg£142.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3840-10mg10mg£182.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3840-25mg25mg£258.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3840-50mg50mg£349.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3840-100mg100mg£485.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Dihydroresveratrol is a major metabolite of resveratrol that is produced by animal-associated bacteria, including the gut microbiota. Dihydroresveratrol and dihydroresveratrol monosulfate are detectable in urine. The physiological effects of dihydroresveratrol have not been investigated.
CAS:
58436-28-5
Formula:
C14H14O3
Molecular Weight:
230.263
Pathway:
Endocrinology/Hormones;
Purity:
0.9968
SMILES:
Oc1ccc(CCc2cc(O)cc(O)c2)cc1
Target:
Estrogen Receptor/ERR;

References

Jung, C.M.,Heinze, T.M.,Schnackenberg, L.K., et al.Interaction of dietary resveratrol with animal-associated bacteria. FEMS Microbiology Letters. 2009, 297(2),266-273. Bode, L.M.,Bunzel, B.,Huch, M., et al. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. American Journal of Clinical Nutrition. 2013,97(2), 295-309. Wang, D.,Hang, T.,Wu, C., et al. Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS. Journal of Chromatography.B, Analytical Technologies in the Biomedical and Life Sciences. 2005, 829(1-2), 97-106.